FDA Inspection 1072711 — Nationwide Laboratories, LLC

Nationwide Laboratories, LLC — FEI 3012555723

The FDA completed an inspection of Nationwide Laboratories, LLC on Nov 27, 2018 in Iselin, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 27, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Iselin, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
1002221 CFR 310.305(a)Failure to develop written procedures
110521 CFR 211.22(d)Procedures not in writing, fully followed
900121 CFR 211.22(a)Lack of quality control unit

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.